Cargando…
TCTN2: a novel tumor marker with oncogenic properties
Tectonic family member 2 (TCTN2) encodes a transmembrane protein that belongs to the tectonic family, which is involved in ciliary functions. Previous studies have demonstrated the role of tectonics in regulating a variety of signaling pathways at the transition zone of cilia. However, the role of t...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707019/ https://www.ncbi.nlm.nih.gov/pubmed/29221125 http://dx.doi.org/10.18632/oncotarget.20438 |
_version_ | 1783282337351467008 |
---|---|
author | Cano-Rodriguez, David Campagnoli, Susanna Grandi, Alberto Parri, Matteo Camilli, Elisa De Song, Chaojun Jin, Boquan Lacombe, Aurelien Pierleoni, Andrea Bombaci, Mauro Cordiglieri, Chiara Ruiters, Marcel HJ Viale, Giuseppe Terracciano, Luigi Sarmientos, Paolo Abrignani, Sergio Grandi, Guido Pileri, Piero Rots, Marianne G. Grifantini, Renata |
author_facet | Cano-Rodriguez, David Campagnoli, Susanna Grandi, Alberto Parri, Matteo Camilli, Elisa De Song, Chaojun Jin, Boquan Lacombe, Aurelien Pierleoni, Andrea Bombaci, Mauro Cordiglieri, Chiara Ruiters, Marcel HJ Viale, Giuseppe Terracciano, Luigi Sarmientos, Paolo Abrignani, Sergio Grandi, Guido Pileri, Piero Rots, Marianne G. Grifantini, Renata |
author_sort | Cano-Rodriguez, David |
collection | PubMed |
description | Tectonic family member 2 (TCTN2) encodes a transmembrane protein that belongs to the tectonic family, which is involved in ciliary functions. Previous studies have demonstrated the role of tectonics in regulating a variety of signaling pathways at the transition zone of cilia. However, the role of tectonics in cancer is still unclear. Here we identify that TCTN2 is overexpressed in colorectal, lung and ovary cancers. We show that different cancer cell lines express the protein that localizes at the plasma membrane, facing the intracellular milieu. TCTN2 over-expression in cancer cells resulted in an increased ability to form colonies in an anchorage independent way. On the other hand, downregulation of TCTN2 using targeted epigenetic editing in cancer cells significantly reduced colony formation, cell invasiveness, increased apoptosis and impaired assembly of primary cilia. Taken together, our results indicate that TCTN2 acts as an oncogene, making it an interesting cancer-associated protein and a potential candidate for therapeutic applications. |
format | Online Article Text |
id | pubmed-5707019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57070192017-12-07 TCTN2: a novel tumor marker with oncogenic properties Cano-Rodriguez, David Campagnoli, Susanna Grandi, Alberto Parri, Matteo Camilli, Elisa De Song, Chaojun Jin, Boquan Lacombe, Aurelien Pierleoni, Andrea Bombaci, Mauro Cordiglieri, Chiara Ruiters, Marcel HJ Viale, Giuseppe Terracciano, Luigi Sarmientos, Paolo Abrignani, Sergio Grandi, Guido Pileri, Piero Rots, Marianne G. Grifantini, Renata Oncotarget Research Paper Tectonic family member 2 (TCTN2) encodes a transmembrane protein that belongs to the tectonic family, which is involved in ciliary functions. Previous studies have demonstrated the role of tectonics in regulating a variety of signaling pathways at the transition zone of cilia. However, the role of tectonics in cancer is still unclear. Here we identify that TCTN2 is overexpressed in colorectal, lung and ovary cancers. We show that different cancer cell lines express the protein that localizes at the plasma membrane, facing the intracellular milieu. TCTN2 over-expression in cancer cells resulted in an increased ability to form colonies in an anchorage independent way. On the other hand, downregulation of TCTN2 using targeted epigenetic editing in cancer cells significantly reduced colony formation, cell invasiveness, increased apoptosis and impaired assembly of primary cilia. Taken together, our results indicate that TCTN2 acts as an oncogene, making it an interesting cancer-associated protein and a potential candidate for therapeutic applications. Impact Journals LLC 2017-08-24 /pmc/articles/PMC5707019/ /pubmed/29221125 http://dx.doi.org/10.18632/oncotarget.20438 Text en Copyright: © 2017 Cano-Rodriguez et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Cano-Rodriguez, David Campagnoli, Susanna Grandi, Alberto Parri, Matteo Camilli, Elisa De Song, Chaojun Jin, Boquan Lacombe, Aurelien Pierleoni, Andrea Bombaci, Mauro Cordiglieri, Chiara Ruiters, Marcel HJ Viale, Giuseppe Terracciano, Luigi Sarmientos, Paolo Abrignani, Sergio Grandi, Guido Pileri, Piero Rots, Marianne G. Grifantini, Renata TCTN2: a novel tumor marker with oncogenic properties |
title | TCTN2: a novel tumor marker with oncogenic properties |
title_full | TCTN2: a novel tumor marker with oncogenic properties |
title_fullStr | TCTN2: a novel tumor marker with oncogenic properties |
title_full_unstemmed | TCTN2: a novel tumor marker with oncogenic properties |
title_short | TCTN2: a novel tumor marker with oncogenic properties |
title_sort | tctn2: a novel tumor marker with oncogenic properties |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707019/ https://www.ncbi.nlm.nih.gov/pubmed/29221125 http://dx.doi.org/10.18632/oncotarget.20438 |
work_keys_str_mv | AT canorodriguezdavid tctn2anoveltumormarkerwithoncogenicproperties AT campagnolisusanna tctn2anoveltumormarkerwithoncogenicproperties AT grandialberto tctn2anoveltumormarkerwithoncogenicproperties AT parrimatteo tctn2anoveltumormarkerwithoncogenicproperties AT camillielisade tctn2anoveltumormarkerwithoncogenicproperties AT songchaojun tctn2anoveltumormarkerwithoncogenicproperties AT jinboquan tctn2anoveltumormarkerwithoncogenicproperties AT lacombeaurelien tctn2anoveltumormarkerwithoncogenicproperties AT pierleoniandrea tctn2anoveltumormarkerwithoncogenicproperties AT bombacimauro tctn2anoveltumormarkerwithoncogenicproperties AT cordiglierichiara tctn2anoveltumormarkerwithoncogenicproperties AT ruitersmarcelhj tctn2anoveltumormarkerwithoncogenicproperties AT vialegiuseppe tctn2anoveltumormarkerwithoncogenicproperties AT terraccianoluigi tctn2anoveltumormarkerwithoncogenicproperties AT sarmientospaolo tctn2anoveltumormarkerwithoncogenicproperties AT abrignanisergio tctn2anoveltumormarkerwithoncogenicproperties AT grandiguido tctn2anoveltumormarkerwithoncogenicproperties AT pileripiero tctn2anoveltumormarkerwithoncogenicproperties AT rotsmarianneg tctn2anoveltumormarkerwithoncogenicproperties AT grifantinirenata tctn2anoveltumormarkerwithoncogenicproperties |